Novotech Showcases Asia-Pacific Success as a Rare Diseases Clinical Trial Hub
Hong Kong - Novotech, a leading biotech specialist CRO in the Asia-Pacific region this month showcases its rare diseases
John Moller, Novotech CEO, signs the #IStandForRespect pledge, joining over 220 CEOs
Media Release 27 August 2021
Novotech Awarded 2021 Frost & Sullivan Asia-Pacific CRO Company of the Year for Fifth Consecutive Year
Novotech Health Holdings Pte. Ltd.
Novotech Joins Decentralized Trials & Research Alliance (Dtra) To Democratize And Accelerate Clinical Trials
Hong Kong – July 20th , 2021 – Novotech Health Holdings Pte. Ltd.
Novotech expands virtual clinical trials capabilities
NEW YORK – July 1, 2021 - ObvioHealth, a global Virtual Research Organization (VRO), announces it has raised $31 million
Novotech Certified as a Great Workplace by Global Authority on Workplace Culture for Second Consecutive Year
Sydney - Australia – Novotech, the largest biotech specialist CRO in the Asia-Pacific region, has again been certified a
Starting Your Clinical Journey With The End In Mind – The Value Of A Drug Development Plan
Establishing an intelligent clinical development program pathway from the start is vital for clarity around the complex processes require
Celebrating International Day for Women and Girls in Science 2021
Thursday 11 February 2021
Novotech Health Holdings Appoints Andy Liu as Head of China
SHANGHAI and SYDNEY, Jan.
Novotech South Korea Celebrates 100th Employee as Biotechs Turn to the Asia-Pacific for Study Continuity
A leading Asia-Pacific biotech specialist CRO Novotech celebrates its 100th employee appointment at the Seoul, South Korea office.
Novotech Health Holdings Appoints Zidong Zhang as CFO
SHANGHAI and SYDNEY, 29 December 2020 – Novotech Health Holdings (“Novotech Holdings”), the largest biotech specialist c